Ines P Marques
Overview
Explore the profile of Ines P Marques including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santos A, Lopes M, Santos T, Reste-Ferreira D, Marques I, Yamaguchi T, et al.
Ophthalmol Ther
. 2024 Oct;
13(12):3161-3173.
PMID: 39460896
Introduction: This study aimed to evaluate intraretinal microvascular abnormalities (IRMA) in eyes with advanced nonproliferative diabetic retinopathy (NPDR) using multimodal approach in co-located areas focusing on central retina (up to...
2.
Marques I, Ribeiro M, Santos T, Mendes L, Reste-Ferreira D, Santos A, et al.
Ophthalmol Ther
. 2022 Dec;
12(1):485-500.
PMID: 36495395
Introduction: Characterization of 2-year progression of different risk phenotypes in eyes with mild and moderate nonproliferative diabetic retinopathy (NPDR) in type 2 diabetes (T2D). Methods: A 2-year prospective longitudinal cohort...
3.
Ribeiro L, Marques I, Santos T, Carvalho S, Santos A, Mendes L, et al.
Ophthalmic Res
. 2022 Sep;
66(1):228-237.
PMID: 36170808
Introduction: The aim of the study was to characterize the 2-year progression of risk phenotypes of nonproliferative diabetic retinopathy (NPDR) in type 2 diabetes (T2D) phenotype C, or ischemic phenotype,...
4.
Madeira M, Marques I, Ferreira S, Tavares D, Santos T, Santos A, et al.
Front Neurosci
. 2022 Jun;
15:800004.
PMID: 35757010
Diabetic retinopathy (DR) has been considered a microvascular disease, but it has become evident that neurodegeneration also plays a key role in this complex pathology. Indeed, this complexity is reflected...
5.
Marques I, Ferreira S, Santos T, Madeira M, Santos A, Mendes L, et al.
Ophthalmologica
. 2022 Feb;
245(4):335-341.
PMID: 35158351
Objective And Purpose: The aim of this study was to explore the relation between retinal neurodegenerative changes and vessel closure (VC) in individuals with nonproliferative diabetic retinopathy (NPDR) in a...
6.
Lobo C, Santos T, Marques I, Madeira M, Santos A, Figueira J, et al.
Eye (Lond)
. 2022 Jan;
37(2):313-319.
PMID: 35066579
Background/objectives: To characterise the prevalence and three-year progression of centre-involving diabetic macular oedema (CI-DMO) in minimal to moderate non-proliferative diabetic retinopathy, using optical coherence tomography (OCT) and measurements of retinal...
7.
Mendes L, Marques I, Cunha-Vaz J
Front Neurosci
. 2021 Dec;
15:755730.
PMID: 34916900
Retinal vessel metrics identifying microvascular changes such as vessel closure (VC) have shown potential clinical value by identifying eyes with diabetic retinopathy (DR) at different severity levels and at increased...
8.
Ribeiro L, Marques I, Coimbra R, Santos T, Madeira M, Santos A, et al.
Ophthalmol Ther
. 2021 Dec;
11(1):333-345.
PMID: 34865186
Introduction: We characterized the progression of different diabetic retinopathy (DR) phenotypes in type 2 diabetes (T2D). Methods: A prospective longitudinal cohort study (CORDIS, NCT03696810) was conducted with three visits (baseline,...
9.
Vujosevic S, Cunha-Vaz J, Figueira J, Lowenstein A, Midena E, Parravano M, et al.
Ophthalmic Res
. 2021 Aug;
64(6):871-887.
PMID: 34348330
Optical coherence tomography Angiography (OCT-A) represents a revolution in the noninvasive evaluation of retinal and choroidal circulation especially in detecting early clinical signs of diabetic retinal disease (DRD). With appropriate...
10.
Marques I, Kubach S, Santos T, Mendes L, Madeira M, De Sisternes L, et al.
J Clin Med
. 2021 Jun;
10(11).
PMID: 34070479
To examine retinal vessel closure metrics and neurodegenerative changes occurring in the initial stages of nonproliferative diabetic retinopathy (NPDR) and severity progression in a three-year period. Three-year prospective longitudinal observational...